This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200603-341OCv1 200603-341OCv2 173/12/1335    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Arcaroli, J. Articles by Abraham, E. Search for Related Content PubMed PubMed Citation Articles by Arcaroli, J. Articles by Abraham, E.

Variant IRAK-1 Haplotype Is Associated with Increased Nuclear Factor–B Activation and Worse Outcomes in Sepsis

Intensive Care Unit, Albert Einstein Hospital and Division of Applied Physiology, Heart Institute, University of Sao Paulo, Sao Paulo, Brazil; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, and Department of Biostatistics, National Jewish Medical and Research Center, Denver, Colorado

Correspondence and requests for reprints should be addressed to Edward Abraham, M.D., Department of Medicine, Chairman's Office, University of Alabama at Birmingham, 1530 3rd Avenue South, BDB 420, Birmingham, AL 35294-0012. E-mail: eabraham{at}uab.edu

Rationale: The IL-1 receptor–associated kinase (IRAK-1) plays a central role in TLR2- and TLR4-induced activation of nuclear factor (NF)-B, a critical event in the transcriptional regulation of many sepsis-associated proinflammatory mediators. There are two haplotypes for the IRAK-1 gene in Caucasians, with the variant haplotype consisting of five intron single-nucleotide polymorphisms (SNPs) and three exon SNPs.

Objectives: To examine the functional significance of the IRAK-1 variant haplotype in modifying nuclear translocation of NF-B and affecting outcomes from sepsis.

Measurements and Main Results: One hundred fifty-five Caucasian patients with sepsis were included. Twenty-one (14%) were homozygous for the IRAK-1 variant haplotype as determined by a SNP in which T is replaced with C at nucleotide 1,595 within exon 12 of the IRAK-1 gene. The IRAK-1 variant haplotype was associated with increased nuclear levels of NF-B in LPS-stimulated peripheral blood neutrophils from patients with sepsis compared with that found in patients with wild-type IRAK-1 haplotype (p = 0.0009). There was an increased incidence of shock (p = 0.047) (odds ratio [OR], 2.9; 95% confidence interval [CI], 1.1–7.7), greater requirement for more prolonged mechanical ventilator support (p = 0.04) (OR, 2.7; 95% CI, 1.05–6.9), and higher 60-d mortality (p = 0.05) (OR, 2.7; 95% CI, 1.0–6.8) in patients with the IRAK-1 variant haplotype compared with wild type.

Conclusions: These results indicate that the IRAK-1 variant haplotype is functionally significant in patients with sepsis, being associated with increased nuclear translocation of NF-B, more severe organ dysfunction, and higher mortality.

Key Words: acute lung injury • haplotype, inflammation • neutrophil • NF- • B • single nucleotide polymorphism

This article has been cited by other articles:

				U. Maitra, S. Davis, C. M. Reilly, and L. Li Differential Regulation of Foxp3 and IL-17 Expression in CD4 T Helper Cells by IRAK-1 J. Immunol., May 1, 2009; 182(9): 5763 - 5769. [Abstract] [Full Text] [PDF]

				T. H. Mogensen Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses Clin. Microbiol. Rev., April 1, 2009; 22(2): 240 - 273. [Abstract] [Full Text] [PDF]

				G. Liu, Y.-J. Park, and E. Abraham Interleukin-1 receptor-associated kinase (IRAK) -1-mediated NF-{kappa}B activation requires cytosolic and nuclear activity FASEB J, July 1, 2008; 22(7): 2285 - 2296. [Abstract] [Full Text] [PDF]

				J. L. Sperry and J. P. Minei Gender dimorphism following injury: making the connection from bench to bedside J. Leukoc. Biol., March 1, 2008; 83(3): 499 - 506. [Abstract] [Full Text] [PDF]

				G. Liu, Y. Tsuruta, Z. Gao, Y.-J. Park, and E. Abraham Variant IL-1 Receptor-Associated Kinase-1 Mediates Increased NF-{kappa}B Activity J. Immunol., September 15, 2007; 179(6): 4125 - 4134. [Abstract] [Full Text] [PDF]

				S. J. Chapman, C. C. Khor, F. O. Vannberg, A. Frodsham, A. Walley, N. A. Maskell, C. W. H. Davies, S. Segal, C. E. Moore, S. H. Gillespie, et al. I{kappa}B Genetic Polymorphisms and Invasive Pneumococcal Disease Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 181 - 187. [Abstract] [Full Text] [PDF]

				E. B. Milbrandt, A. Ishizaka, and D. C. Angus Update in Critical Care 2006 Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 638 - 648. [Full Text] [PDF]

				N. Cartwright, O. Murch, S. K. McMaster, M. J. Paul-Clark, D. A. van Heel, B. Ryffel, V. F. J. Quesniaux, T. W. Evans, C. Thiemermann, and J. A. Mitchell Selective NOD1 Agonists Cause Shock and Organ Injury/Dysfunction In Vivo Am. J. Respir. Crit. Care Med., March 15, 2007; 175(6): 595 - 603. [Abstract] [Full Text] [PDF]

				E. Abraham Periarterial leukocyte accumulation in allergic airway inflammation. Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 841 - 841. [Full Text] [PDF]

				M. Eisenhut Therapeutic Options for Pulmonary Edema Associated with Nuclear Factor-{kappa}B Activation in Septicemia. Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 840b - 8841. [Full Text] [PDF]